Head-to-Head: which drug works best for sudden joint pain in seniors?

NCT ID NCT03128905

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two drugs, colchicine and prednisone, to see which works better for sudden, severe joint pain caused by CPPD arthritis (a type of arthritis common in older adults). The trial involved 111 hospitalized patients aged 65 and older. Researchers measured pain relief after 24 hours and tracked side effects. This is the first large, randomized trial to directly compare these treatments for this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
colchicine or prednisone
What this could lead to
If this trial shows one drug is safer or more effective, it could guide doctors in choosing the best treatment for painful CPPD arthritis in older patients.
What could go wrong
This is a relatively small study (111 people) and both drugs have known side effects, especially in elderly patients with other health issues. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHONDROCALCINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Valenciennes

    Valenciennes, Hauts-de-France, 59322, France

  • CHRU Lille

    Lille, Hauts-de-France, 59000, France

  • Dr Nicolas SEGAUD

    Armentières, 59280, France

  • Dr Rémi LEROY

    Dunkirk, 59240, France

  • Hôpital Bichat

    Paris, Île-de-France Region, 75018, France

  • Hôpital de Lariboisière

    Paris, Île-de-France Region, 75010, France

  • Lille Catholic Hospital

    Lille, Hauts-de-France, 59462, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.